Article
Oncology
Roman C. Maron, Justin G. Schlager, Sarah Haggenmuller, Christof von Kalle, Jochen S. Utikal, Friedegund Meier, Frank F. Gellrich, Sarah Hobelsberger, Axel Hauschild, Lars French, Lucie Heinzerling, Max Schlaak, Kamran Ghoreschi, Franz J. Hilke, Gabriela Poch, Markus Heppt, Carola Berking, Sebastian Haferkamp, Wiebke Sondermann, Dirk Schadendorf, Bastian Schilling, Matthias Goebeler, Eva Krieghoff-Henning, Achim Hekler, Stefan Frohling, Daniel B. Lipka, Jakob N. Kather, Titus J. Brinker
Summary: The study aimed to establish a benchmark for skin cancer classification on dermoscopic images to measure classifier robustness to out-of-distribution (OOD) data. By creating three datasets and evaluating the robustness of four different CNN architectures, it was found that all CNNs showed susceptibility to corruptions and perturbations.
EUROPEAN JOURNAL OF CANCER
(2021)
Article
Oncology
Sui-Han Wang, Guoqiao Chen, Xin Zhong, Tianyu Lin, Yan Shen, Xiaoxiao Fan, Liping Cao
Summary: This study aims to explore the hotspots and trends of artificial intelligence (AI) in cancer research. By retrieving and analyzing relevant literature, the study summarized the publication trends, influential scholars, collaborations, and research focus in AI-based cancer research. The findings provide a foundation for future research.
FRONTIERS IN ONCOLOGY
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Takuma Usuzaki, Kengo Takahashi, Hidenobu Takagi, Mami Ishikuro, Taku Obara, Takumi Yamaura, Masahiro Kamimoto, Kazuhiro Majima
Summary: This study aimed to evaluate the performance of a CNN combined with exponentiating each pixel value in classifying benign and malignant lung nodules on CT images. The study used images from the LIDC-IDRI and constructed four CNN models to classify the nodules by malignancy level. The exponentiation method improved the accuracy and allowed for adjustment of sensitivity and specificity by selecting an appropriate exponent value.
EUROPEAN RADIOLOGY
(2023)
Review
Health Care Sciences & Services
Abdulrahman Takiddin, Jens Schneider, Yin Yang, Alaa Abd-Alrazaq, Mowafa Househ
Summary: AI tools are being used to detect and classify skin cancer efficiently, with shallow and deep machine learning techniques being utilized. This study aimed to identify and group different AI-based technologies used for skin cancer diagnosis, analyzing the correlation between data set size, diagnostic classes, and model performance. Results showed that studies with smaller data sets tended to report higher accuracy, but direct comparisons between methods were hindered by varied evaluation metrics and image types.
JOURNAL OF MEDICAL INTERNET RESEARCH
(2021)
Review
Computer Science, Information Systems
Pat Vatiwutipong, Sirawich Vachmanus, Thanapon Noraset, Suppawong Tuarob
Summary: In the past decade, dermatology has made significant advancements through the use of artificial intelligence (AI) technologies. AI has been utilized for screening, diagnosis, treatment, and prediction of treatment outcomes. While previous systematic reviews have focused on medical dermatology, the adoption of AI in cosmetic dermatology has not been comprehensively reviewed. This systematic review aims to analyze existing research and recent advancements in AI applications within the field of cosmetic dermatology.
Review
Microbiology
Te Sun, Xueli Niu, Qing He, Fujun Chen, Rui-Qun Qi
Summary: Microorganisms are closely linked to skin diseases, and imbalances or invasions of external pathogens can cause various skin diseases. The development and prognosis of these diseases are closely related to the type and composition of microorganisms present. Therefore, detecting the characteristics and changes in microorganisms can greatly improve the diagnosis and prediction of skin diseases.
FRONTIERS IN MICROBIOLOGY
(2023)
Review
Medicine, General & Internal
Ana Maria Malciu, Mihai Lupu, Vlad Mihai Voiculescu
Summary: Reflectance confocal microscopy (RCM) is a non-invasive imaging method designed for identifying various skin diseases, but the diagnosis process may be subjective. Deep learning technologies and machine learning algorithms developed in recent years provide a more objective approach to RCM image analysis, reducing artifacts and evaluation times.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Computer Science, Artificial Intelligence
Prasanalakshmi Balaji, Bui Thanh Hung, Prasun Chakrabarti, Tulika Chakrabarti, Ahmed A. Elngar, Rajanikanth Aluvalu
Summary: This article introduces a new method for early prediction of skin cancer cells using an Artificial Golden Eagle-based Random Forest (AGEbRF), and compares it with previous studies to demonstrate better accuracy.
PEERJ COMPUTER SCIENCE
(2023)
Review
Dermatology
Varadraj Vasant Pai, Rohini Bhat Pai
Summary: Artificial intelligence has been widely applied in various aspects of medicine, with medical imaging being one of the key areas of application. However, there are limitations such as large data requirements, data interpretation, and ethical concerns that need to be addressed as its applications continue to grow.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY
(2021)
Review
Oncology
Navneet Melarkode, Kathiravan Srinivasan, Saeed Mian Qaisar, Pawel Plawiak
Summary: This research aims to explore the use of deep learning and machine learning techniques for diagnosing skin cancer. It discusses the challenges and future directions in this field, as well as compares widely used datasets and review papers on skin cancer diagnosis using AI. The authors of this study aim to establish a benchmark for further research in this field and address the limitations and benefits of historical approaches.
Review
Oncology
Haleigh Stafford, Jane Buell, Elizabeth Chiang, Uma Ramesh, Michael Migden, Priyadharsini Nagarajan, Moran Amit, Dan Yaniv
Summary: Non-melanoma skin cancer is a common and increasing cancer diagnosis globally. Deep learning, a type of artificial intelligence, has shown promise in aiding in the diagnosis of non-melanoma skin cancer. This review discusses the evidence, available technologies and remote applications, and attitudes and ethical considerations related to deep learning in skin cancer screening and diagnosis.
Article
Multidisciplinary Sciences
Thomas McGrath, Andrei Kapishnikov, Nenad Tomasev, Adam Pearce, Martin Wattenberg, Demis Hassabis, Been Kim, Ulrich Paquet, Vladimir Kramnik
Summary: AlphaZero, a neural network engine that learns chess solely by playing against itself, acquires knowledge that enables it to outperform human chess players. Despite training without access to human games or guidance, it appears to learn concepts similar to those used by human chess players, as evidenced by linear probes and behavioral analysis.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2022)
Review
Gastroenterology & Hepatology
Julien Calderaro, Tobias Paul Seraphin, Tom Luedde, Tracey G. Simon
Summary: Hepatocellular carcinoma (HCC) is a growing malignancy with increasing incidence and mortality rates globally. Artificial intelligence (AI) provides a unique opportunity to enhance HCC risk prediction, diagnosis, and prognostication. Machine learning (ML) and deep learning (DL) models, applied to diverse data sources, have shown promising results in improving accuracy of HCC risk prediction, detection, and treatment response prediction. However, further research is needed to address challenges related to standardizing AI data and ensuring interpretability of results.
JOURNAL OF HEPATOLOGY
(2022)
Article
Computer Science, Information Systems
Michelle S. Lee, Lisa N. Guo, Vinod E. Nambudiri
Summary: The article discusses the potential gender biases that may arise when using machine learning and artificial intelligence technologies in dermatology, emphasizing the importance of considering gender differences to ensure the accuracy of ML/AI algorithms.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
(2021)
Article
Computer Science, Artificial Intelligence
Khaled Rjoob, Raymond Bond, Dewar Finlay, Victoria McGilligan, Stephen J. Leslie, Ali Rababah, Aleeha Iftikhar, Daniel Guldenring, Charles Knoery, Anne McShane, Aaron Peace, Peter W. Macfarlane
Summary: This study reviewed the application of machine learning (ML) in analyzing electrocardiogram (ECG) data and used time series analysis to study the changing popularity of different ML algorithms over the past two decades. The results showed that the use of ML in analyzing ECG data has been increasing, especially in heart abnormality classification. Support vector machine has been the most commonly used technique in the past decade, but deep learning has been trending upwards since 2018 and is likely to become the leading technique in the coming years. Accuracy was the most frequently used evaluation metric in the reviewed studies.
ARTIFICIAL INTELLIGENCE IN MEDICINE
(2022)
Article
Dermatology
Johannes Schleusener, Silke B. Lohan, Loris Busch, Kamran Ghoreschi, Neysha Lobo Ploch, Stefanie May, Simone Vogel, Jurgen Eberle, Martina C. Meinke
Summary: Fungal infections have been increasing and becoming resistant to common drugs. UVC light at wavelength 254 nm has shown eradication effects on microorganisms but is highly carcinogenic and mutagenic. To avoid harming skin cells, researchers tested the antifungal effects of UVC light at wavelengths 222 nm and 233 nm. They found that microbicidal doses could be achieved at 40 mJ/cm(2) for both wavelengths, resulting in minimal skin damage.
Article
Oncology
Lucas Schneider, Christoph Wies, Eva I. Krieghoff-Henning, Tabea-Clara Bucher, Jochen S. Utikal, Dirk Schadendorf, Titus J. Brinker
Summary: In this study, the contribution of different data types in a combined classifier for predicting BRAF mutation status in melanoma was analyzed. The multimodal classifier showed improved generalisability compared to individual classifiers.
EUROPEAN JOURNAL OF CANCER
(2023)
Article
Oncology
Alexander C. J. van Akkooi, Dirk Schadendorf, Alexander M. M. Eggermont
Summary: Sentinel lymph node biopsy (SLNB) was introduced in the 1990s to identify patients who may benefit from completion lymph node dissection. SLNB staging has been found to be the best for staging melanoma. Adjuvant systemic therapy and biomarkers are emerging, which might reduce the need for SLNB staging in the future.
EUROPEAN JOURNAL OF CANCER
(2023)
Article
Dermatology
Katharina Schumann, Cornelia Mauch, Kai-Christian Klespe, Carmen Loquai, Ulrike Nikfarjam, Max Schlaak, Larissa Akcetin, Peter Koelblinger, Magdalena Hoellwerth, Markus Meissner, Guelcin Mengi, Andreas Dominik Braun, Miriam Mengoni, Reinhard Dummer, Joanna Mangana, Mihaela-Anca Sindrilaru, Dan Radmann, Christine Hafner, Johann Freund, Klemens Rappersberger, Felix Weihsengruber, Frank Meiss, Lydia Reinhardt, Friedegund Meier, Barbara Rainer, Erika Richtig, Julia Maria Ressler, Christoph Hoeller, Thomas Eigentler, Teresa Amaral, Wiebke K. Peitsch, Uwe Hillen, Wolfgang Harth, Fabian Ziller, Kerstin Schatton, Thilo Gambichler, Laura Susok, Lara Valeska Maul, Heinz Laubli, Dirk Debus, Carsten Weishaupt, Sevil Boerger, Katharina Sievers, Sebastian Haferkamp, Veronika Zenderowski, Van Anh Nguyen, Marina Wanner, Ralf Gutzmer, Patrick Terheyden, Katharina Kaehler, Steffen Emmert, Alexander Thiem, Michael Sachse, Silke Gercken-Riedel, Kjell Matthias Kaune, Kai-Martin Thoms, Lucie Heinzerling, Markus Vincent Heppt, Sabine Tratzmiller, Wolfram Hoetzenecker, Angela Oellinger, Andreas Steiner, Tobias Peinhaupt, Maurizio Podda, Sabine Schmid, Uwe Wollina, Tilo Biedermann, Christian Posch
Summary: This real-world study examines the clinical outcomes of adjuvant melanoma treatment using PD-1 antibodies and BRAF + MEK inhibitors in specialized skin cancer centers in Germany, Austria, and Switzerland. The results show that patients treated with PD-1 antibodies have a lower 12-month recurrence rate compared to patients treated with BRAF + MEK inhibitors. Additionally, PD-1 antibody treatment is not affected by BRAF mutation status.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
(2023)
Article
Dermatology
Alexander Thiem, Pegah Mashhadiakbar, Christiane Cussigh, Jessica C. Hassel, Imke Grimmelmann, Ralf Gutzmer, Max Schlaak, Markus Heppt, Pia Duecker, Svea Huening, Lena Schulmeyer, Bastian Schilling, Sebastian Haferkamp, Mirjana Ziemer, Rose K. C. Moritz, Victoria Hagelstein, Patrick Terheyden, Christian Posch, Maria R. Gaiser, Peter Kropp, Steffen Emmert, Britta Mueller, Julia K. Tietze
Summary: This study investigated the impact of disease and treatment on the daily life of patients receiving systemic therapy for melanoma. The results showed that immune checkpoint inhibition might be preferred over targeted therapy in terms of quality of life and adverse events in the adjuvant setting, and older patients with melanoma were less impacted by their disease and more satisfied with their treatment.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
(2023)
Article
Dermatology
Jan-Malte Placke, Delphine Mertens, Alpaslan Tasdogan, Eleftheria Chorti, Dirk Schadendorf, Selma Ugurel, Alexander Roesch, Ingo Stoffels, Joachim Klode
Summary: This study demonstrates that multispectral optoacoustic tomography (MSOT) can differentiate between benign and malignant lymphadenopathy by measuring the levels of oxyhemoglobin and deoxyhemoglobin in lymph nodes. It offers a noninvasive approach to avoid unnecessary lymph node biopsies and surgeries.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
(2023)
Editorial Material
Otorhinolaryngology
Marlene Garzarolli, Olimpiu Bota, Matthias Meinhardt, Tareq Juratli, Friedegund Meier
Summary: This case report illustrates the successful treatment of an elderly patient with advanced squamous cell carcinoma using the monoclonal antibody cemiplimab, leading to complete remission. The interdisciplinary approach and surgical intervention also contributed to the patient's positive outcome.
LARYNGO-RHINO-OTOLOGIE
(2023)
Article
Oncology
Cindy Franklin, Peter Mohr, Leonie Bluhm, Friedegund Meier, Marlene Garzarolli, Michael Weichenthal, Katharina Kaehler, Imke Grimmelmann, Ralf Gutzmer, Jochen Utikal, Patrick Terheyden, Rudolf Herbst, Sebastian Haferkamp, Claudia Pfoehler, Andrea Forschner, Ulrike Leiter, Fabian Ziller, Frank Meiss, Jens Ulrich, Alexander Kreuter, Christoffer Gebhardt, Julia Welzel, Bastian Schilling, Martin Kaatz, Karin Scharfetter-Kochanek, Edgar Dippel, Dorothee Nashan, Michael Sachse, Carsten Weishaupt, Harald Loeffler, Thilo Gambichler, Carmen Loquai, Lucie Heinzerling, Stephan Grabbe, Dirk Debus, Gaston Schley, Jessica C. Hassel, Gerhard Weyandt, Maike Trommer, Georg Lodde, Jan-Malte Placke, Lisa Zimmer, Elisabeth Livingstone, Juergen Christian Becker, Susanne Horn, Dirk Schadendorf, Selma Ugurel
Summary: This study investigated the impact of first-line therapy on the incidence of brain metastasis and survival outcomes in patients with advanced melanoma. It found that BRAF mutant patients treated with PD-1 +/- CTLA-4 inhibitors had a lower occurrence and delayed development of brain metastasis compared to BRAF+MEK targeted therapy. Furthermore, first-line therapy with CTLA-4+PD-1 showed superior overall survival compared to PD-1 and BRAF+MEK.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2023)
Article
Physics, Particles & Fields
L. Nayak, S. Nishida, A. Giri, I. Adachi, H. Aihara, D. M. Asner, H. Atmacan, V. Aulchenko, T. Aushev, R. Ayad, V. Babu, S. Bahinipati, S. Banerjee, M. Bauer, P. Behera, K. Belous, J. Bennett, M. Bessner, B. Bhuyan, D. Biswas, D. Bodrov, J. Borah, A. Bozek, M. Bracko, P. Branchini, T. E. Browder, A. Budano, M. Campajola, D. Cervenkov, M. -c. Chang, B. G. Cheon, K. Chilikin, H. E. Cho, K. Cho, S. -k. Choi, Y. Choi, S. Choudhury, D. Cinabro, J. Cochran, S. Das, N. Dash, G. De Nardo, G. De Pietro, R. Dhamija, F. Di Capua, J. Dingfelder, Z. Dolezal, T. V. Dong, D. Dossett, S. Dubey, D. Epifanov, T. Ferber, D. Ferlewicz, B. G. Fulsom, R. Garg, V. Gaur, P. Goldenzweig, E. Graziani, T. Gu, Y. Guan, S. Halder, T. Hara, K. Hayasaka, H. Hayashii, M. T. Hedges, D. Herrmann, W. -s. Hou, C. -l. Hsu, T. Iijima, K. Inami, G. Inguglia, N. Ipsita, A. Ishikawa, R. Itoh, M. Iwasaki, W. W. Jacobs, E. -j. Jang, S. Jia, Y. Jin, K. K. Joo, A. B. Kaliyar, T. Kawasaki, C. Kiesling, C. H. Kim, D. Y. Kim, K. -h. Kim, Y. -k. Kim, K. Kinoshita, P. Kodys, T. Konno, A. Korobov, S. Korpar, E. Kovalenko, P. Krizan, P. Krokovny, T. Kuhr, M. Kumar, R. Kumar, K. Kumara, A. Kuzmin, Y. -j. Kwon, S. C. Lee, J. Li, L. K. Li, Y. Li, J. Libby, K. Lieret, Y. -r. Lin, D. Liventsev, T. Luo, Y. Ma, M. Masuda, T. Matsuda, S. K. Maurya, F. Meier, M. Merola, F. Metzner, K. Miyabayashi, R. Mizuk, G. B. Mohanty, I. Nakamura, M. Nakao, Z. Natkaniec, A. Natochii, N. K. Nisar, S. Ogawa, H. Ono, P. Oskin, P. Pakhlov, G. Pakhlova, T. Pang, S. Pardi, J. Park, S. -h. Park, A. Passeri, S. Paul, T. K. Pedlar, R. Pestotnik, L. E. Piilonen, T. Podobnik, E. Prencipe, M. T. Prim, A. Rostomyan, N. Rout, G. Russo, S. Sandilya, A. Sangal, L. Santelj, V. Savinov, G. Schnell, C. Schwanda, A. J. Schwartz, Y. Seino, K. Senyo, M. E. Sevior, M. Shapkin, C. Sharma, J. -g. Shiu, A. Sibidanov, E. Solovieva, M. Staric, M. Sumihama, T. Sumiyoshi, M. Takizawa, K. Tanida, F. Tenchini, K. Trabelsi, M. Uchida, Y. Unno, K. Uno, S. Uno, P. Urquijo, S. E. Vahsen, G. Varner, K. E. Varvell, A. Vinokurova, D. Wang, M. -z. Wang, S. Watanuki, E. Won, B. D. Yabsley, W. Yan, J. Yelton, Y. Yook, C. Z. Yuan, L. Yuan, Y. Yusa, Y. Zhai, Z. P. Zhang, V. Zhilich, V. Zhukova
Summary: In this study, we searched for lepton-flavor-violating decays B-s(0) -> l(-/+) tau(+/-) using the full data sample collected at the Belle detector. No evidence for B-0(s) -> l(-/+) tau(+/-) decays was found, and upper limits on their branching fractions were set.
JOURNAL OF HIGH ENERGY PHYSICS
(2023)
Article
Oncology
Elias A. T. Koch, Anne Petzold, Anja Wessely, Edgar Dippel, Markus Eckstein, Anja Gesierich, Ralf Gutzmer, Jessica C. Hassel, Harald Knorr, Nicole Kreuzberg, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Markus Meissner, Peter Mohr, Claudia Pfoehler, Farnaz Rahimi, Dirk Schadendorf, Max Schlaak, Kai-Martin Thoms, Selma Ugurel, Jochen Utikal, Michael Weichenthal, Beatrice Schuler-Thurner, Carola Berking, Markus V. Heppt
Summary: Metastases of uveal melanoma predominantly spread to the liver. Liver-directed therapies (LDT) are commonly used for tumor control in patients with low response rates to systemic therapies. This study compared the outcomes of patients with metastatic UM treated with immune checkpoint blockade (ICB), with and without LDT, and found that the combination of LDT with ICB was associated with longer overall survival, improved progression-free survival, and higher treatment response rates.
FRONTIERS OF MEDICINE
(2023)
Article
Oncology
Daniel Truhn, Chiara M. L. Loeffler, Gustav Mueller-Franzes, Sven Nebelung, Katherine J. Hewitt, Sebastian Brandner, Keno K. Bressem, Sebastian Foersch, Jakob Nikolas Kather
Summary: The study demonstrates that large language models, like GPT-4, can extract structured data from unstructured pathology reports with high concordance to human-generated structured data, potentially enabling routine extraction of ground truth data for machine learning.
JOURNAL OF PATHOLOGY
(2023)
Article
Oncology
Philipp Jansen, Jean Le 'Clerc Arrastia, Daniel Otero Baguer, Maximilian Schmidt, Jennifer Landsberg, Joerg Wenzel, Michael Emberger, Dirk Schadendorf, Eva Hadaschik, Peter Maass, Klaus Georg Griewank
Summary: This study highlights the enormous potential of artificial intelligence in pathology, showing that it can aid in the identification of rare cutaneous adnexal tumors and potentially become a standard tool in routine diagnostics.
EUROPEAN JOURNAL OF CANCER
(2024)
Proceedings Paper
Computer Science, Artificial Intelligence
Firas Khader, Gustav Mueller-Franzes, Soroosh Tayebi Arasteh, Tianyu Han, Jakob Nikolas Kather, Johannes Stegmaier, Sven Nebelung, Daniel Truhn
Summary: We present an innovative method that combines out-of-distribution detection and image generation using vector-quantized autoencoder and normalizing flow models. The technique is demonstrated on a medical knee radiograph dataset, aiming to alleviate the quality control burden of radiologists and improve image standardization during acquisition.
2023 IEEE 20TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING, ISBI
(2023)
Article
Medicine, Research & Experimental
Jan Clusmann, Fiona R. Kolbinger, Hannah Sophie Muti, Zunamys I. Carrero, Jan-Niklas Eckardt, Narmin Ghaffari Laleh, Chiara Maria Lavinia Loeffler, Sophie-Caroline Schwarzkopf, Michaela Unger, Gregory P. Veldhuizen, Sophia J. Wagner, Jakob Nikolas Kather
Summary: This article provides a systematic and comprehensive overview of the potentials and limitations of large language models (LLMs) in clinical practice, medical research, and medical education. It highlights the potential of LLMs to democratize medical knowledge and facilitate access to healthcare, while also pointing out the risks of misinformation and scientific misconduct due to a lack of accountability and transparency.
COMMUNICATIONS MEDICINE
(2023)
Meeting Abstract
Gastroenterology & Hepatology
Qinghe Zeng, Christophe Klein, Stefano Caruso, Pascale Maille, Daniela Allende, Beatriz Minguez, Massimo Iavarone, Massih Ningarhari, Andrea Casadei Gardini, Federica Pedica, Margherita Rimini, Riccardo Perbellini, Camille Boulagnon-Rombi, Alexandra Heurgue-Berlot, Marco Maggioni, Mohd. Rela, Mukul Vij, Sylvain Baulande, Patricia Legoix, Sonia Lameiras, Ismail Labgaa, Christine Sempoux, Antonia Digkilia, Narmin Ghaffari-Laleh, Jakob Nikolas Kather, Omar El Nahhas, Pooja Navale, Callie Torres, Tung-Hung Su, Rondell Graham, Maria Salcedo, Maria Bermudez, Nguyen H. Tran, Jean-Michel Pawlotsky, Gontran Verset, Eric Trepo, Maria Varela, Andres Castano-Garcia, Dominique Wendum, Giuliana Amaddeo, Helene Regnault, Marie Lequoy, Alba Diaz, Maria Reig, Pompilia Radu, Jean-Francois Dufour, Stephen Chan, Purva Gopal, Lea Bruges, Viviane Gnemmi, Jean Charles Nault, Hyungjin Rhee, Young Nyun Park, Mercedes Inarrairaegui, Josep Maria Argemi, Bruno Sangro, Antonio D'Alessio, Bernhard Scheiner, David J. Pinato, Matthias Pinter, Valerie Paradis, Aurelie Beaufrere, Simon Peter, Lorenza Rimassa, Luca Di Tommaso, Arndt Vogel, Sophie Michalak, Jerome Boursier, Nicolas Lomenie, Marianne Ziol, Julien Calderaro
JOURNAL OF HEPATOLOGY
(2023)
Article
Oncology
Diego de Miguel-Perez, Edward M. Pickering, Umberto Malapelle, William Grier, Francesco Pepe, Pasquale Pisapia, Gianluca Russo, Joseph A. Pinto, Alessandro Russo, Giancarlo Troncone, Melissa J. Culligan, Katherine A. Scilla, Ranee Mehra, Pranshu Mohindra, Oscar Arrieta, Andres F. Cardona, Marzia Del Re, Ashutosh Sachdeva, Fred R. Hirsch, Andrea Wolf, Joseph S. Friedberg, Christian Rolfo
Summary: In this study, genetic alterations in resectable pleural mesothelioma tissues and blood samples were analyzed, and it was found that high tissue tumor mutational burden, tissue median minor allele frequency, blood tumor mutational burden, and specific mutations were correlated with outcomes in patients with resected PM. These findings suggest that molecular profiling could help identify longer survivors in patients with resected PM.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Davide Melisi, Camilla Zecchetto, Valeria Merz, Giuseppe Malleo, Luca Landoni, Alberto Quinzii, Simona Casalino, Federica Fazzini, Marina Gaule, Camilla Pesoni, Luca Casetti, Alessandro Esposito, Giovanni Marchegiani, Cristiana Piazzola, Mirko D'Onofrio, Riccardo de Robertis, Armando Gabbrielli, Laura Bernardoni, Stefano F. Crino, Silvia Pietrobono, Claudio Luchini, Camillo Aliberti, Guido Martignoni, Stefano Milleri, Giovanni Butturini, Aldo Scarpa, Roberto Salvia, Claudio Bassi
Summary: This study evaluated the safety and activity of liposomal irinotecan in the perioperative treatment of resectable pancreatic ductal adenocarcinoma (rPDAC) patients. The results showed that NALIRIFOX has manageable and active outcomes, and should be further investigated in randomized trials comparing it to standard upfront surgery followed by adjuvant therapy.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Eric Jonasch, Todd M. Bauer, Kyriakos P. Papadopoulos, Elizabeth R. Plimack, Jaime R. Merchan, David F. Mcdermott, M. Dror Michaelson, Leonard J. Appleman, Ananya Roy, Rodolfo F. Perini, Yanfang Liu, Toni K. Choueiri
Summary: After a median follow-up of 41.2 months, belzutifan monotherapy demonstrated durable antitumor activity in patients with advanced ccRCC and acceptable safety.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Patricia A. H. Hamers, Geraldine R. Vink, Marloes A. G. Elferink, Leon M. G. Moons, Cornelis J. A. Punt, Anne M. May, Miriam Koopman
Summary: Screen-detection of the primary tumor is associated with longer overall survival after metachronous metastasis.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Camilla Nero, Nicolo Bizzarri, Stefano Di Berardino, Francesca Sillano, Giuseppe Vizzielli, Francesco Cosentino, Virginia Vargiu, Pierandrea De Iaco, Anna Myriam Perrone, Enrico Vizza, Benito Chiofalo, Stefano Uccella, Fabio Ghezzi, Luigi Carlo Turco, Giacomo Corrado, Diana Giannarelli, Tina Pasciuto, Gian Franco Zannoni, Anna Fagotti, Giovanni Scambia
Summary: This study evaluates the sensitivity and specificity of sentinel-lymph-node mapping compared to systematic lymphadenectomy in detecting lymph node metastasis in early stage ovarian cancer. The results show that sentinel-lymph-node mapping did not reach the expected sensitivity, but ultra-staging protocol improved the accuracy of diagnosis for patients.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Adriana Hepner, Judith M. Versluis, Roslyn Wallace, Clara Allayous, Lauren Julia Brown, Claudia Trojanielloh, Camille Lea Gerardi, Yanina J. L. Jansenj, Prachi Bhave, Bart Neyns, Andrew Haydon, Olivier Michielin, Joanna Manganan Oliver Klein, Alexander N. Shoushtari, Allison Betof Warner, Paolo Antonio Ascierto, Jennifer Leigh McQuade, Matteo S. Carlino, Lisa Zimmer, Celeste Lebbe, Douglas B. Johnson, Shahneen Sandhu, Victoria Atkinson, Christian U. Blank, Serigne N. Lo, Georgina V. Long, Alexander M. Menzies
Summary: Acquired resistance to PD-1 therapy in melanoma is mainly oligometastatic, and patients may have a favorable survival outcome following salvage treatment.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Savannah Roy, Stephanie Lakritz, Anna R. Schreiber, Elizabeth Molina Kuna, Cathy J. Bradley, Lavanya Kondapalli, Jennifer R. Diamond
Summary: This study evaluates major adverse cardiovascular events (MACE) in older women with TNBC treated with anthracycline and taxane-based chemotherapy (ATAX) compared to taxane-based chemotherapy (TAX). The results show that ATAX does not increase the risk of MACE and there is no difference in survival between patients who received TAX and ATAX.
EUROPEAN JOURNAL OF CANCER
(2024)
Letter
Oncology
Pei-Chun Weng, Yau-Li Huang, Chun-Yu Cheng
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Philipp Jansen, Jean Le 'Clerc Arrastia, Daniel Otero Baguer, Maximilian Schmidt, Jennifer Landsberg, Joerg Wenzel, Michael Emberger, Dirk Schadendorf, Eva Hadaschik, Peter Maass, Klaus Georg Griewank
Summary: This study highlights the enormous potential of artificial intelligence in pathology, showing that it can aid in the identification of rare cutaneous adnexal tumors and potentially become a standard tool in routine diagnostics.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Casper W. F. van Eijck, Gaby Strijk, Eveline E. Vietscha, Fleur van der Sijde, Maaike Verheij, Dana A. M. Mustafa, Madelief Vinkc, Joachim G. J. V. Aerts, Casper H. J. van Eijck, Marcella Willemsen
Summary: The study reveals that FOLFIRINOX has immunomodulatory effects, suggesting its potential in immune-based combination therapies for pancreatic cancer. Additionally, certain plasma proteins hold promise as circulating predictive biomarkers for early prediction of FOLFIRINOX response in patients with pancreatic cancer.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Marwan Fakih, Chongkai Wang, Jaideep Sandhu, Jian Ye, Colt Egelston, Xiaochen Li
Summary: This study explores the impact of metastatic sites on treatment outcomes for chemotherapy-refractory colorectal cancer patients. It found that patients with liver or peritoneal metastases had poor treatment outcomes, while those with lung-only metastases showed significant response. The presence of concurrent lymph node or other extrahepatic metastatic disease diminished treatment response in patients with lung metastases. Future checkpoint inhibitor trials should stratify patients based on metastatic locations.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Georgios Christos Tsiatsianis, Candace S. Y. Chan, Ioannis Mouratidis, Nikol Chantzi, Anna Maria Tsiatsiani, Nelson S. Yee, Apostolos Zaravinos, Verena Kantere, Ilias Georgakopoulos-Soares
Summary: The study reveals that nullpeptides can serve as biomarkers for cancer detection and treatment, particularly in highly recurrent cancer patients. These nullpeptides primarily occur in highly expressed genes, particularly in specific loci of oncogenes and tumor suppressors. Recurrent nullpeptides are more likely to be found in neoantigens, which play a significant role in immunotherapy.
EUROPEAN JOURNAL OF CANCER
(2024)